Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05769426

NCT05769426
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • People of any race or ethnicity are welcome
  • Women between 18 and 40 years old who are of childbearing age (for the PCOS pre-menopause group only)
  • Women aged 50 or older who have gone through menopause naturally, meaning no period for at least the last 12 months (for the PCOS post-menopause and control post-menopause groups only)
  • Women who score 3 or higher on a self-screening questionnaire for PCOS, and/or have been diagnosed with PCOS by a doctor (for the PCOS groups only)
  • Women with no history of PCOS or excess male hormones who score 0–2 on the PCOS screening questionnaire (for the control post-menopause group only)
  • People who have access to a phone, tablet, or computer that can make video calls (for the PCOS groups only)
  • People with a body mass index (a measure of body weight relative to height) between 18.5 and 40
  • People who can read and speak English

Who may not be able to join:

  • People who currently smoke
  • People who have issues with alcohol use
  • People who are currently pregnant or breastfeeding
  • People who have been diagnosed with or treated for cancer in the last 3 years (except a common, less serious type of skin cancer called basal cell carcinoma)
  • People who have used hormone replacement therapy in the last 3 months
  • People whose menopause was caused by surgery, such as removal of the ovaries
  • People who are currently incarcerated
  • People with any other health condition or circumstance that the study doctors decide makes participation unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
The University of Texas Medical Branch, Galveston
Registry
clinicaltrials_gov
Start date
27 March 2023
Est. completion
31 August 2024

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Qualitative Interview; PROMIS Physical Function (10a); PROMIS Fatigue; PROMIS Sleep Disturbance; PROMIS Sleep-related Impairment; PROMIS Depression; PROMIS Anxiety; PROMIS Satisfaction with roles and abilities; PROMIS Ability to participate in social roles and activity; Exercise Self-Efficacy Scale; Eating at America's Table Study survey; Height; Weight; Whole body lean mass; Appendicular lean mass; Total fat mass; Visceral fat mass; Total cholesterol; LDL cholesterol; HDL cholesterol; Triglycerides; Glucose; Insulin; Hemoglobin A1C; Estradiol; Testosterone; Androstenedione; Sex hormone bindin...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov